This Review summarizes the data on medical treatment of patients with prolactinomas. In particular, the authors focus on previous findings of an association between cardiac valve disease and treatment with dopamine agonists in patients with hyperprolactinemia and on the possibility that permanent control of prolactin levels can be achieved after withdrawal from these drugs.
- Annamaria Colao
- Silvia Savastano